The role of minimally invasive diagnostic techniques in optimizing treatment strategies in patients with colorectal cancer
DOI:
https://doi.org/10.30978/GS-2025-3-43Keywords:
colorectal cancer, diagnostic laparoscopy, carcinomatosis, mediastinoscopy, staging, metastasis, NCCNAbstract
Objective – to improve staging accuracy and optimize therapeutic strategies in patients with colorectal cancer by performing minimally invasive diagnostic procedures, specifically diagnostic laparoscopy with peritoneal lavage and cytological examination, and mediastinoscopy with targeted lymph node biopsy, in cases where conventional imaging methods (computed tomography [CT], magnetic resonance imaging [MRI], positron emission tomography combined with computed tomography [PET‑CT]) yield equivocal or inconclusive results.
Materials and methods. This ambispective (retrospective–prospective) study was conducted from 2023 to 2025 and included 37 patients with colorectal cancer who had inconclusive standard imaging results regarding distant metastases or peritoneal carcinomatosis. Patients were allocated into two groups: 22 patients with suspected peritoneal carcinomatosis underwent diagnostic laparoscopy with peritoneal lavage, peritoneal biopsy, and cytological analysis, while 15 patients with suspected mediastinal lymph node involvement underwent cervical mediastinoscopy with targeted lymph node biopsy. Diagnostic accuracy, the impact of findings on subsequent therapeutic management, and procedural safety were evaluated.
Results. Peritoneal carcinomatosis was morphologically confirmed in 19 of 22 patients (86.4%), and metastatic involvement of mediastinal lymph nodes was confirmed in 11 of 15 patients (73.3%). Verification of the pathological process resulted in a change in therapeutic strategy for 29 of 37 patients (78.4%). Specifically, 27 patients (73.0%) received systemic chemotherapy, 7 patients (18.9%) underwent radical surgical procedures, 2 patients (5.4%) underwent palliative resection, and 1 patient (2.7%) declined further treatment. No serious intraoperative complications were observed. Minor postoperative events, including pain at the puncture site, subcutaneous emphysema, and transient fever, occurred in 8 patients (21.6%) and did not require additional treatment.
Conclusions. Incorporating diagnostic laparoscopy and mediastinoscopy into the colorectal cancer staging algorithm yields high diagnostic accuracy, supporting personalized treatment planning. The application of minimally invasive methods reduces unnecessary surgical interventions, shortens the time to initiation of systemic therapy, and may improve prognosis in patients with advanced disease.
References
Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10-32. http://doi.org/10.1016/j.annonc.2022.10.003.
Clinical Outcomes of Surgical Therapy Study Group; Nelson H, Sargent DJ, Wieand HS, Fleshman J, Anvari M, Stryker SJ, Beart RW Jr, Hellinger M, Flanagan R Jr, Peters W, Ota D. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004 May 13;350(20):2050-9. http://doi.org/10.1056/NEJMoa032651. PMID: 15141043.
Kobayashi H, Kotake K, Maeda K, et al. Peritoneal lavage cytology in patients with curative resection for stage II and III colorectal cancer: a multi-institutional prospective study. Ann Gastroenterol Surg. 2024;8(5):807-816. http://doi.org/10.1002/ags3.12825.
Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl 6):vi64-vi72. http://doi.org/10.1093/annonc/mdt354.
Lafaro KJ, Roumanis P, Demirjian AN, Lall C, Imagawa DK. Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon’s Perspective! Int J Hepatol. 2013;2013:572307. http://doi.org/10.1155/2013/572307. Epub 2013 Apr 9. PMID: 23653860; PMCID: PMC3638698.
Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, Sugiura A, Cohen AS, Ali A, Do BT, Muir A, Lewis CA, Hongo RA, Young KL, Brown RE, Todd VM, Huffstater T, Abraham A, O’Neil RT, Wilson MH, Xin F, Tantawy MN, Merryman WD, Johnson RW, Williams CS, Mason EF, Mason FM, Beckermann KE, Vander Heiden MG, Manning HC, Rathmell JC, Rathmell WK. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021 May;593(7858):282-288. http://doi.org/10.1038/s41586-021-03442-1. Epub 2021 Apr 7. PMID: 33828302; PMCID: PMC8122068.
Schena CA, Laterza V, De Sio D, Quero G, Fiorillo C, Gunawardena G, Strippoli A, Tondolo V, de’Angelis N, Alfieri S, Rosa F. The Role of Staging Laparoscopy for Gastric Cancer Patients: Current Evidence and Future Perspectives. Cancers (Basel). 2023 Jun 30;15(13):3425. http://doi.org/10.3390/cancers15133425. PMID: 37444535; PMCID: PMC10340245.
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012 Oct;23(10):2479-2516. http://doi.org/10.1093/annonc/mds236. PMID: 23012255.
Sugarbaker PH. Peritoneal Carcinomatosis: Principles of Management. Berlin: Springer; 1996. 256 p.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. http://doi.org/10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Tsukada T, Nakano T, Matoba M, Sasaki S, Higashi K. False-Positive Mediastinal Lymphadenopathy on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography after Rectal Cancer Resection: A Case Report of Thoracoscopic Surgery in the Prone Position. Case Rep Oncol. 2011 Sep;4(3):569-75. http://doi.org/10.1159/000335017. Epub 2011 Dec 7. PMID: 22220152; PMCID: PMC3251247.
Van Cutsem E, Cervantes A, Adam R, et al. ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer. Ann Oncol. 2016;27(8):1386-1422. http://doi.org/10.1093/annonc/mdw235.
Vandecaveye V, Rousset P, Nougaret S, Stepanyan A, Otero-Garcia M, Nikolić O, Hameed M, Goffin K, de Hingh IHJ, Lahaye MJ; European Society of Gastrointestinal and Abdominal Radiology (ESGAR); European Society of Urogenital Radiology (ESUR); Peritoneal Surface Oncology Group International (PSOGI); European Association of Nuclear Medicine (EANM). Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM. Eur Radiol. 2025 May;35(5):2712-2722. http://doi.org/10.1007/s00330-024-11124-5. Epub 2024 Nov 5. PMID: 39499302; PMCID: PMC12021955.
Yamamoto S, Akasu T, Fujita S, Moriya Y. Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol. 2003 Jan;33(1):33-7. http://doi.org/10.1093/jjco/hyg007. PMID: 12604722.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
